Physician profile
Anne Wold
NPI 1427031061
$826.19
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2022: $45.93 · 2023: $57.39 · 2024: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $211.93 | 2023-2024 | |
| Therapeuticsmd, INC. | $125.00 | 2019 | |
| Sumitomo Pharma America, INC. | $107.08 | 2023-2024 | Myfembree |
| Organon LLC | $98.99 | 2024 | |
| Abbvie INC. | $68.84 | 2019-2024 | |
| Biogen, INC. | $49.42 | 2024 | Zurzuvae |
| Shield Therapeutics INC | $46.51 | 2024 | |
| Scynexis, INC. | $27.92 | 2022 | |
| Coopersurgical, INC. | $24.28 | 2024 | Paragard T 380a |
| Agile Therapeutics, INC. | $18.80 | 2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $18.01 | 2022 | |
| Exeltis, USA INC. | $17.90 | 2024 | Slynd |
| Emd Serono, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Wold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.